<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37688413</PMID><DateRevised><Year>2023</Year><Month>09</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-2299</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2023</Year><Month>Sep</Month><Day>09</Day></PubDate></JournalIssue><Title>Drug development research</Title><ISOAbbreviation>Drug Dev Res</ISOAbbreviation></Journal><ArticleTitle>Virucidal activity of trehalose 6-monolaurate against dengue virus in vitro.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1002/ddr.22112</ELocationID><Abstract><AbstractText>Dengue fever is an acute febrile disease caused by dengue virus (DENV) infection. Over the past 60 years, DENV has spread throughout tropical regions and currently affects more than 50% of the world's population; however, there are as of yet no effective anti-DENV drugs for clinical treatment. A number of research teams have investigated derivatives of glycolipids as possible agents for the inhibition of DENV. Our objective in this research was to study the antiviral effects of trehalose 6-caprate (TMC), trehalose 6-monolaurate (TML), and trehalose 6-monooleate (TMO), based on reports that the corresponding glycosyl, trehalose, reduces the transmission of Zika virus (ZIKV). We also sought to elucidate the molecular mechanisms underlying inhibition using the RNA isolation and reverse transcription-quantitative polymerase chain reaction, western blot analysis, median tissue culture infectious dose (TCID<sub>50</sub> ) assay, and immunofluorescence assay&#xa0;and immunochemistry&#xa0;staining, in vitro. This is the first study to demonstrate the TML-induced inhibition of DENV serotype 2 (DENV-2) in a dose-dependent manner. The inhibitory effects of TML in the pretreated, cotreated, and full-treated groups were confirmed using time of addition assays. We determined that TML restricted viral binding, entry, replication, and release. We also confirmed the efficacy of TML against three clinical isolates of DENV serotypes 1, 3, and 4 (DENV-1, DENV-3, and DENV-4). The findings obtained in this study identify TML as a promising candidate for the development of drugs to treat DENV infection.</AbstractText><CopyrightInformation>&#xa9; 2023 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Jeng-Wei</ForeName><Initials>JW</Initials><Identifier Source="ORCID">0000-0003-2128-2046</Identifier><AffiliationInfo><Affiliation>Biotech Research and Innovation Centre, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Finsen Laboratory, Rigshospitalet/National University Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chin-Kai</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>School of Pharmacy, National Defense Medical Center, Taipei, Taiwan, ROC.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy, Tri-Service General Hospital Penghu Branch, National Defense Medical Center, Magong City, Taiwan, ROC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yen-Chen</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>School of Pharmacy, National Defense Medical Center, Taipei, Taiwan, ROC.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Preventive Medicine, National Defense Medical Center, New Taipei, Taiwan, ROC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Guan-Chiun</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>School of Life Science, National Taiwan Normal University, Taipei, Taiwan, ROC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Yi-Jung</ForeName><Initials>YJ</Initials><Identifier Source="ORCID">0009-0006-3931-2302</Identifier><AffiliationInfo><Affiliation>School of Pharmacy, National Defense Medical Center, Taipei, Taiwan, ROC.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, ROC.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MOST110-2320-B-016-006-</GrantID><Agency>Ministry of Science and Technology,&#xa0;Taiwan, ROC</Agency><Country/></Grant><Grant><GrantID>MOST111-2628-B-016-003-MY3</GrantID><Agency>Ministry of Science and Technology,&#xa0;Taiwan, ROC</Agency><Country/></Grant><Grant><GrantID>MND-MAB-110-007</GrantID><Agency>Ministry of National Defense, Taiwan, ROC</Agency><Country/></Grant><Grant><GrantID>MND-MAB-C10-111039</GrantID><Agency>Ministry of National Defense, Taiwan, ROC</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Drug Dev Res</MedlineTA><NlmUniqueID>8204468</NlmUniqueID><ISSNLinking>0272-4391</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antiviral</Keyword><Keyword MajorTopicYN="N">binding</Keyword><Keyword MajorTopicYN="N">dengue virus</Keyword><Keyword MajorTopicYN="N">entry</Keyword><Keyword MajorTopicYN="N">stability</Keyword><Keyword MajorTopicYN="N">trehalose 6-monolaurate</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>9</Day><Hour>11</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>9</Day><Hour>11</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>9</Day><Hour>3</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37688413</ArticleId><ArticleId IdType="doi">10.1002/ddr.22112</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Aguiar, M., Stollenwerk, N., &amp; Halstead, S. B. (2016). The impact of the newly licensed dengue vaccine in endemic countries. PLoS Neglected Tropical Diseases, 10(12), e0005179.</Citation></Reference><Reference><Citation>Bhatt, S., Gething, P. W., Brady, O. J., Messina, J. P., Farlow, A. W., Moyes, C. L., Drake, J. M., Brownstein, J. S., Hoen, A. G., Sankoh, O., Myers, M. F., George, D. B., Jaenisch, T., Wint, G. R. W., Simmons, C. P., Scott, T. W., Farrar, J. J., &amp; Hay, S. I. (2013). The global distribution and burden of dengue. Nature, 496(7446), 504-507.</Citation></Reference><Reference><Citation>Brady, O. J., Gething, P. W., Bhatt, S., Messina, J. P., Brownstein, J. S., Hoen, A. G., Moyes, C. L., Farlow, A. W., Scott, T. W., &amp; Hay, S. I. (2012). Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Neglected Tropical Diseases, 6(8), e1760.</Citation></Reference><Reference><Citation>Carnec, X., Meertens, L., Dejarnac, O., Perera-Lecoin, M., Hafirassou, M. L., Kitaura, J., Ramdasi, R., Schwartz, O., &amp; Amara, A. (2016). The phosphatidylserine and phosphatidylethanolamine receptor CD300a binds dengue virus and enhances infection. Journal of Virology, 90(1), 92-102.</Citation></Reference><Reference><Citation>Chen, Y. C., Lu, J. W., Yeh, C. T., Lin, T. Y., Liu, F. C., &amp; Ho, Y. J. (2021). Micafungin inhibits dengue virus infection through the disruption of virus binding, entry, and stability. Pharmaceuticals, 14(4), 338.</Citation></Reference><Reference><Citation>Cruz-Oliveira, C., Freire, J. M., Concei&#xe7;&#xe3;o, T. M., Higa, L. M., Castanho, M. A. R. B., &amp; Da Poian, A. T. (2015). Receptors and routes of dengue virus entry into the host cells. FEMS Microbiology Reviews, 39(2), 155-170.</Citation></Reference><Reference><Citation>Fikatas, A., Vervaeke, P., Meyen, E., Llor, N., Ordeix, S., Boonen, I., Bletsa, M., Kafetzopoulou, L. E., Lemey, P., Amat, M., Pannecouque, C., &amp; Schols, D. (2021). A novel series of indole alkaloid derivatives inhibit dengue and zika virus infection by interference with the viral replication complex. Antimicrobial Agents and Chemotherapy, 65(8), e0234920.</Citation></Reference><Reference><Citation>Halstead, S. B. (2006). Dengue in the Americas and Southeast Asia: Do they differ? Revista Panamericana de Salud P&#xfa;blica, 20(6), 407-415.</Citation></Reference><Reference><Citation>Halstead, S. B., &amp; Cohen, S. N. (2015). Dengue hemorrhagic fever at 60 years: Early evolution of concepts of causation and treatment. Microbiology and Molecular Biology Reviews, 79(3), 281-291.</Citation></Reference><Reference><Citation>Ho, Y. J., Liu, F. C., Yeh, C. T., Yang, C. M., Lin, C. C., Lin, T. Y., Hsieh, P. S., Hu, M. K., Gong, Z., &amp; Lu, J. W. (2018). Micafungin is a novel anti-viral agent of chikungunya virus through multiple mechanisms. Antiviral Research, 159, 134-142.</Citation></Reference><Reference><Citation>Kale, S. S., &amp; Akamanchi, K. G. (2016). Trehalose monooleate: A potential antiaggregation agent for stabilization of proteins. Molecular Pharmaceutics, 13(12), 4082-4093.</Citation></Reference><Reference><Citation>Low, J. G. H., Ooi, E. E., &amp; Vasudevan, S. G. (2017). Current status of dengue therapeutics research and development. The Journal of Infectious Diseases, 215(Suppl 2), S96-S102.</Citation></Reference><Reference><Citation>Lu, J. W., Chen, Y. C., Huang, C. K., Lin, K. C., &amp; Ho, Y. J. (2021). Synergistic in-vitro antiviral effects of combination treatment using anidulafungin and T-1105 against Zika virus infection. Antiviral Research, 195, 105188.</Citation></Reference><Reference><Citation>McMinn, P. C. (1997). The molecular basis of virulence of the encephalitogenic flaviviruses. Journal of General Virology, 78(Pt 11), 2711-2722.</Citation></Reference><Reference><Citation>Meertens, L., Carnec, X., Lecoin, M. P., Ramdasi, R., Guivel-Benhassine, F., Lew, E., Lemke, G., Schwartz, O., &amp; Amara, A. (2012). The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell Host &amp; Microbe, 12(4), 544-557.</Citation></Reference><Reference><Citation>Mukhopadhyay, S., Kuhn, R. J., &amp; Rossmann, M. G. (2005). A structural perspective of the flavivirus life cycle. Nature Reviews Microbiology, 3(1), 13-22.</Citation></Reference><Reference><Citation>Pandejpong, D., Saengsuri, P., Rattarittamrong, R., Rujipattanakul, T., &amp; Chouriyagune, C. (2015). Is excessive acetaminophen intake associated with transaminitis in adult patients with dengue fever? Internal Medicine Journal, 45(6), 653-658.</Citation></Reference><Reference><Citation>Rattanaburee, T., Junking, M., Panya, A., Sawasdee, N., Songprakhon, P., Suttitheptumrong, A., Limjindaporn, T., Haegeman, G., &amp; Yenchitsomanus, P. (2015). Inhibition of dengue virus production and cytokine/chemokine expression by ribavirin and compound A. Antiviral Research, 124, 83-92.</Citation></Reference><Reference><Citation>Reddy, T., &amp; Sansom, M. S. P. (2016). The role of the membrane in the structure and biophysical robustness of the dengue virion envelope. Structure, 24(3), 375-382.</Citation></Reference><Reference><Citation>Richard, A. S., Zhang, A., Park, S. J., Farzan, M., Zong, M., &amp; Choe, H. (2015). Virion-associated phosphatidylethanolamine promotes TIM1-mediated infection by Ebola, dengue, and West Nile viruses. Proceedings of the National Academy of Sciences, 112(47), 14682-14687.</Citation></Reference><Reference><Citation>Rigau-P&#xe9;rez, J. G., Clark, G. G., Gubler, D. J., Reiter, P., Sanders, E. J., &amp; Vance Vorndam, A. (1998). Dengue and dengue haemorrhagic fever. The Lancet, 352(9132), 971-977.</Citation></Reference><Reference><Citation>Roth, H., Magg, V., Uch, F., Mutz, P., Klein, P., Haneke, K., Lohmann, V., Bartenschlager, R., Fackler, O. T., Locker, N., Stoecklin, G., &amp; Ruggieri, A. (2017). Flavivirus infection uncouples translation suppression from cellular stress responses. mBio, 8(1), e02150-16. https://journals.asm.org/doi/full/10.1128/mbio.02150-16?rfr_dat=cr_pub++0pubmed&amp;url_ver=Z39.88-2003&amp;rfr_id=ori%3Arid%3Acrossref.org</Citation></Reference><Reference><Citation>Sanaki, T., Wakabayashi, M., Yoshioka, T., Yoshida, R., Shishido, T., Hall, W. W., Sawa, H., &amp; Sato, A. (2019). Inhibition of dengue virus infection by 1-stearoyl-2-arachidonoyl-phosphatidylinositol in vitro. The FASEB Journal, 33(12), 13866-13881.</Citation></Reference><Reference><Citation>Schaeffer, E., Flacher, V., Neuberg, P., Hoste, A., Brulefert, A., Fauny, J. D., Wagner, A., &amp; Mueller, C. G. (2018). Inhibition of dengue virus infection by mannoside glycolipid conjugates. Antiviral Research, 154, 116-123.</Citation></Reference><Reference><Citation>Simo, F. B. N., Bigna, J. J., Kenmoe, S., Ndangang, M. S., Temfack, E., Moundipa, P. F., &amp; Demanou, M. (2019). Dengue virus infection in people residing in Africa: A systematic review and meta-analysis of prevalence studies. Scientific Reports, 9(1), 13626.</Citation></Reference><Reference><Citation>Smith, J. L., Stein, D. A., Shum, D., Fischer, M. A., Radu, C., Bhinder, B., Djaballah, H., Nelson, J. A., Fr&#xfc;h, K., &amp; Hirsch, A. J. (2014). Inhibition of dengue virus replication by a class of small-molecule compounds that antagonize dopamine receptor d4 and downstream mitogen-activated protein kinase signaling. Journal of Virology, 88(10), 5533-5542.</Citation></Reference><Reference><Citation>Srikiatkhachorn, A., Krautrachue, A., Ratanaprakarn, W., Wongtapradit, L., Nithipanya, N., Kalayanarooj, S., Nisalak, A., Thomas, S. J., Gibbons, R. V., Mammen, M. P., Libraty, D. H., Ennis, F. A., Rothman, A. L., &amp; Green, S. (2007). Natural history of plasma leakage in dengue hemorrhagic fever: A serial ultrasonographic study. Pediatric Infectious Disease Journal, 26(4), 283-290; discussion 291-282.</Citation></Reference><Reference><Citation>St John, A. L., &amp; Rathore, A. P. S. (2019). Adaptive immune responses to primary and secondary dengue virus infections. Nature Reviews Immunology, 19(4), 218-230.</Citation></Reference><Reference><Citation>Stiasny, K., Allison, S. L., Marchler-Bauer, A., Kunz, C., &amp; Heinz, F. X. (1996). Structural requirements for low-pH-induced rearrangements in the envelope glycoprotein of tick-borne encephalitis virus. Journal of Virology, 70(11), 8142-8147.</Citation></Reference><Reference><Citation>Tully, D., &amp; Griffiths, C. L. (2021). Dengvaxia: The world's first vaccine for prevention of secondary dengue. Therapeutic Advances in Vaccines and Immunotherapy, 9, 251513552110158.</Citation></Reference><Reference><Citation>Wan, Y., Wu, W., Zhang, J., Li, L., Wan, Y., Tang, X., Chen, X., Liu, S., &amp; Yao, X. (2021). Tenovin-1 inhibited dengue virus replication through SIRT2. European Journal of Pharmacology, 907, 174264.</Citation></Reference><Reference><Citation>Wong, R. R., Abd-Aziz, N., Affendi, S., &amp; Poh, C. L. (2020). Role of microRNAs in antiviral responses to dengue infection. Journal of Biomedical Science, 27(1), 4.</Citation></Reference><Reference><Citation>Yuan, S., Zhang, Z. W., &amp; Li, Z. L. (2017). Trehalose may decrease&#xa0;the transmission of Zika virus to the fetus by activating degradative autophagy. Frontiers in Cellular and Infection Microbiology, 7, 402.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>